SEAVI Advent

SEAVI Advent is a private equity and venture capital firm established in 1984 and headquartered in Singapore, with additional offices in Hong Kong and Shanghai. As the first venture capital firm in Southeast Asia, it focuses on growth capital investments across various stages, including early-stage, mid-stage, and later-stage companies. SEAVI Advent primarily targets sectors such as business services, healthcare, consumer-related businesses, industrial technology, and environmental engineering. The firm seeks investment opportunities in the Asia Pacific region, particularly in Singapore, Malaysia, Hong Kong, Indonesia, and Mainland China. Typically, SEAVI Advent invests between $5 million and $25 million in companies with enterprise values ranging from $25 million to $100 million. The firm also prefers to take an active role in its portfolio companies by securing seats on their boards of directors.

Kevin Chan

Senior Partner

Hoe Boon Kwee

CFO and Partner

Derrick Lee

CEO and Managing Partner

Daniel Poh

Partner

Teo Yi-Dar

Senior Partner and Member of Investment Committee

Henry Yao Wei Min

Partner

1 past transactions

Sinocom Pharmaceutical

Series A in 2009
Sinocom Pharmaceutical, Inc., a pharmaceutical company, grows and sells natural herbs in the People's Republic of China. The company also sells various third party traditional Chinese medicine formulated products and western medicines. Its pharmaceutical products include over-the-counter and prescription pharmaceuticals. The company sells its products to hospitals, medical clinics, drug stores, and distributors. Sinocom Pharmaceutical, Inc. was founded in 1997 and is based in Central, Hong Kong.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.